You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm appointed Richard Eberly, formerly a managing director at private equity firm Solid Rock Principled Capital, as CEO.
The collaboration expands on an existing partnership between the companies announced in 2018 to develop POC tests for significant global health threats.
News items for the in vitro diagnostics industry for the week of March 2, 2020.
News items for the in vitro diagnostics industry for the week of Feb. 10, 2020.
The tests performed well, with researchers suggested they could be used for diagnosis in the future, rather than just screening.
News items for the in vitro diagnostics industry for the week of Dec. 30, 2019
Developers pointed to some success, but they also noted that more at-home tests need to demonstrate higher levels of performance and affordability.
At Medica, the two firms, whose tests have received WHO prequalification, said their tests were seeing high adoption rates in lower-resource nations.
Total revenue during the third quarter was impacted by lower product sales in Africa, but the firm said it saw growth in the US, Latin America, and Asia Pacific.
The firm's CEO said that the approval enables global funders and national ministries of health to expand access to HIV self-testing, allowing diagnosis and treatment.